Vascular intervention + products from major manufacturers + huge market

Terumo Aortic’s Fenestrated Treo abdominal aortic stent system is a custom-designed endovascular repair device specifically designed for complex abdominal aortic aneurysms, such as perirenal and suprarenal aneurysms. It has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA).

Based on the standard EVAR platform, this system uses a custom fenestration technique to extend the sealing zone into the visceral artery region, enabling endovascular repair of complex aneurysms involving the renal artery or superior mesenteric artery. Its core principle involves pre-positioning 1-5 fenestrations in the stent body. During the procedure, bridging stents are used to reconstruct blood flow in the target vessel, maintaining organ perfusion while ensuring aneurysm isolation. This system can be used in conjunction with Getinge’s iCast covered stent system or Bentley’s BeFlared dedicated bridging stent.

The Fenestrated Treo features a modular three-piece design (main body + bilateral limbs), with a main body diameter ranging from 20-36 mm, and is equipped with a unique low-profile delivery system (18-19F outer diameter). The stent structure utilizes a self-expanding nickel-titanium alloy serpentine stent with a wide amplitude design and large spacing (approximately 18 mm stent spacing). This feature provides ample operational space for fenestration, facilitating personalized fenestration modifications within the stent gaps.

Proximal fixation employs a two-stage fixation mechanism. The suprenal fixation stent is equipped with five downward-pointing barbs, enabling repositionable release in conjunction with the proximal CLASP system. The distal “stent-locking” mechanism uses five inwardly protruding rods to ensure a secure connection between modules, effectively preventing type III endoleaks and stent migration. The main body is covered with a tightly woven polyester material, reinforced at the fenestration site with nickel-titanium alloy rings.

Another significant feature of this system is the inclusion of a removable indwelling sheath, which can be detached and retained in the body after main body deployment, facilitating subsequent balloon dilation or introduction into the contralateral limb segment, simplifying the surgical procedure. The main body length can reach 49 cm (including a 67 cm handle), suitable for the treatment of type IV thoracic and abdominal aortic aneurysms.

The system has been implanted in more than 1,200 cases in Europe and other regions. The US IDE study is expected to include 210 patients and follow them for 5 years to verify its safety and efficacy in treating perirenal and suprarenal aneurysms.

Vascular intervention